Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centhaquine in Hypovolemic Shock
NCT04045327Phase 3Completed
- Sponsor
- Pharmazz, Inc.
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of centhaquine in hypovolemic shock, sponsored by Pharmazz, Inc.. Started Jan 2019; status: completed.
02
Drugs
centhaquine
03
Conditions
hypovolemic shock
Beyond the preview
Go deeper on NCT04045327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04045327.